Article Text
Therapeutics
Systematic Review with Meta-Analysis
Hysterectomy, endometrial destruction and the levonorgestrel intrauterine system are all effective therapies for heavy menstrual bleeding; satisfaction rates are highest after hysterectomy
Statistics from Altmetric.com
Footnotes
-
Competing interests ISF has received consultancy fees, lecture fees and research funding from Bayer Schering Pharma, Schering Plough (now Merck), Daiichi Sankyo, NIH and NHMRC. He is a member of the International Committee for Contraception Research of the Population Council, New York (which developed the levonorgestrel intrauterine system, LNG IUS) and of the current Bayer Global Advisory Board for the LNG IUS.